Cronos Group reports boosted cannabis revenue but wider losses in Q4

Just Released! Get realistic market forecasts, state-by-state insights and benchmarks with the new 2024 MJBiz Factbook member program, now with quarterly updates. Make informed decisions.

Cronos, Cronos Group reports boosted cannabis revenue but wider losses in Q4

Cronos Group, a Toronto-based licensed cannabis party, posted sizable fourth-quarter revenue, the company said in an earnings report Tuesday, but its net loss for the period grew sharply – fueled in large part by financial reporting requirements.

Cronos reported fourth-quarter revenue of 5.6 million Canadian dollars ($4.2 million) for the period ended Dec. 31, 2018, up nearly 250% from the same period in 2017.

Full-year 2018 gross revenue totaled CA$17.1 million, up 317% from 2017.

The company’s red ink for the year rang in at CA$19.1 million, or 11 Canadian cents a share, compared with net profit of CA$2.5 million in 2017.

During the quarter, Cronos closed a CA$2.4 billion strategic investment from Altria Group.

Shares of Cronos, which trades on the Nasdaq as CRON, slipped nearly 3% in early trading Tuesday morning, opening at $19.65 a share compared with Monday’s closing price of $20.53.

The Ontario company, founded in 2013, cultivates and distributes medical and recreational marijuana in five provinces across Canada.

Lisa Bernard-Kuhn can be reached at

(Get access to more in-depth market analysis, premium features on cannabis investing trends and monthly executive webcasts with an Investor Intelligence subscription.)